$CBRS

Feldman Andrew D. sold $7.9M of CBRS

Feldman Andrew D. (CEO, President) sold 37,441 shares of Cerebras Systems Inc. (CBRS) at an average of $210.46 ($199.18–$216.62, $7.88M total) across 16 trades on 2026-09-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Feldman Andrew D.
Published Sep 9, 2026, 12:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
medium confidence
Mentioned
$CBRS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishLow
01

Why it matters

The reduction in insider ownership may be interpreted by some traders as a lack of confidence, prompting modest sell orders. However, the planned nature of the trade reduces the likelihood of a sudden price shock.

02

Market read

The filing is a primary source of new information for CBRS shareholders and may generate modest short‑term trading activity.

03

What to watch

Potential upcoming product announcements or financing rounds could offset any short‑term pressure from the sale.

Relevance 5/10Novelty 5/10Timing: post‑market filing on Sep 8, 2026

Background

Form 4 filings provide the first public disclosure of insider transactions. This filing reports a CEO‑initiated sale under a pre‑arranged 10b5‑1 plan.

Company-level read

Ticker impact

$CBRSBearishMedium confidence
Context

CEO Andrew Feldman sold 37,441 shares for $7.9 M via a 10b5‑1 plan, reducing his stake to 16,853 shares.

Expected impact

Likely modest downward pressure in the near term as the market digests the CEO's reduction of holdings.

Evidence & confidence

A $7.9 M sale by the CEO is material for a micro‑cap, but the amount is not large enough to trigger a sharp move; the 10b5‑1 plan indicates pre‑planned execution rather than a reaction to news.

Market effects

Minimal impact on the AI‑hardware sector; insider sales are common and do not alter sector fundamentals.

Limited to U.S. investors tracking micro‑cap AI hardware stocks.

Low; the filing is unlikely to affect broader market sentiment.

Counterpoint

The sale could be a routine liquidity event and not indicative of negative outlook; price may remain stable.

Key entities

  • Cerebras Systems Inc.

    AI‑hardware manufacturer listed on NASDAQ under ticker CBRS.

  • Andrew D. Feldman

    CEO and President of Cerebras Systems, reporting the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras stock jumps 9%; Q3 sales guide sets a harder test

Cerebras Systems (CBRS) stock rose 9% after OpenAI's Sam Altman reaffirmed their partnership. The company's Q3 revenue guidance suggests 2.4% sequential growth. OpenAI committed to 750MW of capacity, with an option for 1.25GW. Cerebras reported $56.8M in OpenAI-related revenue in Q2, 31.5% of total GAAP revenue. The stock remains below its IPO price of $185.

$CBRSHigh

CBRS Stock Surges Over 6% in Monday Pre-Market: What's the Sam Altman Connection? - Cerebras Systems (NAS

Cerebras Systems (CBRS) shares rose 6.56% premarket after OpenAI CEO Sam Altman called it a 'close partner,' easing concerns. Analysts noted strong ties with OpenAI, despite Nvidia (NVDA) running its new model. Barclays' Tom O'Malley called the sell-off 'overdone,' while Paul Meeks upgraded CBRS to Buy with a $209 target, citing high AI demand. CBRS is down 52.45% YTD.

$CBRSMed

Mizuho reiterates Cerebras Systems stock rating on inference growth

Mizuho reiterated its Outperform rating and $300 price target for Cerebras Systems (CBRS), citing growth in fast inference workloads. The firm projects a $550B market by 2030, with CBRS trading near its 52-week low at $166.43. CBRS reported 91% revenue growth over the last year, and analysts have revised earnings upwards, though some suggest overvaluation. The company unveiled the CS-4 system, with improved performance and compute density, expected in Q3.